PHAT - Phathom Pharmaceuticals, Inc.
IEX Last Trade
8.02
-0.005 -0.062%
Share volume: 39,571
Last Updated: Thu 26 Dec 2024 08:30:16 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$8.02
-0.01
-0.06%
Summary score
28%
Profitability
26%
Dept financing
25%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0.84%
Return on assets
-6.99%
Return on sales
0%
Return on invested capital
2273.74%
Total debt ratio
151.32%
Debt ratio change over timeo
-0.66%
Current Ratio
34.29%
Quick Ratio
0%
Cash Position Ratio
32.7%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
0.84%
Return on assets
-6.99%
Return on sales
0%
Return on invested capital
2273.74%
Total debt ratio
151.32%
Debt ratio change over timeo
-0.66%
Current Ratio
34.29%
Quick Ratio
0%
Cash Position Ratio
32.7%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-42.99%
Return on assets
-6.1%
Return on sales
0%
Return on invested capital
4514.33%
Total debt ratio
11.36%
Debt ratio change over time
-0.66%
Current Ratio
68.2%
Quick Ratio
0%
Cash Position Ratio
65.04%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-229.68%
Return on assets
-118.4%
Return on sales
0%
Return on invested capital
13516.15%
Total debt ratio
-65.73%
Debt ratio change over time
-0.66%
Current Ratio
204.7%
Quick Ratio
0%
Cash Position Ratio
195.17%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PHAT | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0.84% | 14.1% | 20.07% | 4.28% |
| Return on assets | -6.99% | 3.31% | 11.64% | 3.37% |
| Return on sales | 0% | 23.43% | 42.11% | 26.08% |
| Return on invested capital | 2273.74% | 4.57% | -276.8% | 4.11% |
| Profitability | 26% | 39% | 75% | 28% |
| Total debt ratio | 151.32% | 74.95% | 53.78% | 57.28% |
| Debt ratio change over time | -0.66% | -0.78% | -1.19% | 10.64% |
| Dept financing | 25% | 12% | 9% | 34% |
| Current Ratio | 34.29% | 1.15% | 1.02% | 1.32% |
| Quick Ratio | 0% | 0.87% | 0.72% | 1.04% |
| Cash Position Ratio | 32.7% | 0.18% | 0.25% | 0.52% |
| Liquididy | 50% | 20% | 16% | 27% |
| Short-term ratios | PHAT | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 0.84% | 41.2% | 18.68% | 6.33% |
| Return on assets | -6.99% | 3.76% | 10.92% | 3.39% |
| Return on sales | 0% | 25.91% | 42.67% | 25.57% |
| Return on invested capital | 2273.74% | 8.36% | 78.06% | 4.78% |
| Profitability | 26% | 49% | 62% | 27% |
| Total debt ratio | 151.32% | 92.68% | 55.94% | 61.6% |
| Debt ratio change over time | -0.66% | 12.22% | -0.99% | 12.87% |
| Dept financing | 25% | 39% | 9% | 35% |
| Current Ratio | 34.29% | 1.15% | 1.02% | 1.32% |
| Quick Ratio | 0% | 0.87% | 0.72% | 1.04% |
| Cash Position Ratio | 32.7% | 0.18% | 0.25% | 0.52% |
| Liquididy | 50% | 22% | 18% | 26% |